NCT06725173View on ClinicalTrials.gov

Detailed Phenotypic and Genotype Study to Correlate RB1 Mutations Relating to Primary Ocular Tumors and Secondary Extra-ocular Metastasis.

Active, not recruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

December 1, 2024

Primary Completion Date

January 1, 2030

Study Completion Date

January 1, 2031

Conditions
Retinoblastoma BilateralRetinoblastoma UnilateralRetinoblastoma, ExtraocularRetinoblastoma, RecurrentRetinoblastoma
Interventions
GENETIC

Targeted Long-read sequencing

All patient's will undergo targeted long-read sequencing to resolve genomic and epigenomic signatures of the RB1 gene

Trial Locations (1)

98109

University of Washington, Seattle

All Listed Sponsors
collaborator

National Eye Institute (NEI)

NIH

lead

University of Washington

OTHER

NCT06725173 - Detailed Phenotypic and Genotype Study to Correlate RB1 Mutations Relating to Primary Ocular Tumors and Secondary Extra-ocular Metastasis. | Biotech Hunter | Biotech Hunter